<DOC>
	<DOCNO>NCT01195805</DOCNO>
	<brief_summary>The investigator wish study effect retain potassium . The participant essential hypertension . The test substance Amiloride , Spironolactone placebo . The participant ingest tablet 28 day examine . We perform 24 hour urine collection , 24-hours bloodpressure measurement , blood urine sample also examine patient use SphygmoCor .</brief_summary>
	<brief_title>The Effects Amiloride Spironolactone Renophysiological Cardiovascular Variables</brief_title>
	<detailed_description>Purpose study examine effect amiloride spironolactone 1 . Renal function ( GFR , u-AQP2 , u-ENaCÎ² , u-cAMP , u-PGE2 , CH20 , FENa , FEK ) , 2 . Pulsewave velocity , augmentation index central bloodpressure , 3 . Vasoactive hormone ( PRC , AngII , Aldo , AVP , ANP , BNP Endot ) , 4 . Ambulatory bloodpressure</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>hypertension , BMI 18,530 , nonsmoker Smoking Not use contraceptive Other illness Drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Blood pressure , PWV , HRV , PWV , potassium</keyword>
</DOC>